Skip to main content

The Globe and Mail

Neptune Tech (NEPT-Q) Quote

Unchecking box will stop auto data updates
Cboe BZX Real-Time Last Sale USD
Today's Change
Volume
Price Quote as of

Today's Trading

Day Low 2.85
Day High 2.97
Open:2.94
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Trailing Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Realtime quote and/or trade prices are not sourced from all markets.

More stories below advertisement

Description
Neptune Technologies & Bioressources Inc. develops proprietary and potent health ingredients from underexploited marine biomasses, such as krill, with its patented extraction process. Using its proprietary process, Neptune Technologies & Bioressources Inc. is strategically positioning itself in the nutraceutical and pharmaceutical health and wellness market. The Company develops and markets new formulas and new products for specific applications in high growth markets such the nutraceutical, cosmeceutical, biopharmaceutical and nutrigenomics markets, the next wave in nutritional research.

Fundamentals

Market Capitalization, $M
Shares Outstanding, M
36-Month Beta
Earnings Per Share (TTM)
1-Year Total Return
3-Year Total Return
5-Year Total Return
Price/Earnings (TTM)
Price/Earnings (Forward)
Trailing Annual Dividend & Yield
Forward Annual Dividend & Yield
Most Recent Dividend
Ex-Div Date
Price/Book
Most Recent Split

Earnings

Corporate earnings are provided from Zacks Investment Research, including Income Statements, Balance Sheets, Cash Flow Statements, and Statement of Retained Earnings.

Analyst Research

Analyst Ratings and Earnings Estimates are provided by Zacks Investment Research – including Buy/Hold Recommendations, Earnings Surprises, Estimates and Recommendations History.

Stock Reports +

Download a comprehensive report detailing quantitative analytics of this equity. For subscribers only.

Latest Press Releases

Technical Perspectives on Biotech Stocks -- Neptune Technologies & Bioressources, Neuralstem, NewLink Genetics, and OHR Pharma
PR Newswire - Thu Apr 5, 5:10AM CDT
PR Newswire - CMTX
Thu Apr 5, 5:10AM CDT
WallStEquities.com strives to bring the best free research to the investment community. Today we are offering reports on NEPT, CUR, NLNK, and OHRP which can be accessed for free by signing up to www.wallstequities.com/registration. Today, WallStEquities.com shifts focus on Biotechnology, which focuses on novel drug development and clinical research aimed at treating diseases and medical conditions. Lined up for evaluation this morning are the following four stocks: Neptune Technologies & Bioressources Inc. (NASDAQ: NEPT), Neuralstem Inc. (NASDAQ: CUR), NewLink Genetics Corp. (NASDAQ: NLNK), and OHR Pharmaceutical Inc. (NASDAQ: OHRP). All you have to do is sign up today for this free limited time offer by clicking the link below. www.wallstequities.com/registration
Free Research Reports on These Biotech Stocks -- Navidea Biopharma, Nektar Therapeutics, Mirati Therapeutics, and Neptune Technologies & Bioressources
PR Newswire - Fri Feb 16, 5:35AM CST
PR Newswire - CMTX
Fri Feb 16, 5:35AM CST
WallStEquities.com strives to bring the best free research to the investment community. Today we are offering reports on NAVB, NKTR, MRTX, and NEPT which can be accessed for free by signing up to www.wallstequities.com/registration. This morning, WallStEquities.com draws investors' attention to the Biotechnology space, which comprises companies that use biological systems or living organisms for the development of their products. Under monitoring today are: Navidea Biopharmaceuticals Inc. (NYSEAMER: NAVB), Nektar Therapeutics (NASDAQ: NKTR), Mirati Therapeutics Inc. (NASDAQ: MRTX), and Neptune Technologies & Bioressources Inc. (NASDAQ: NEPT). All you have to do is sign up today for this free limited time offer by clicking the link below.
Neptune Announces Third Quarter Results
Marketwire - Wed Feb 14, 3:00PM CST
Marketwire - CMTX
Wed Feb 14, 3:00PM CST
Cannabis Business Development Underway and On Schedule
Price History Describes more index sector components

Price Performance

Period Period Low Period High Performance
1-Month 2.61 +10.34% increase
on 03/28/18
Period Open:2.96
Price movement based on the high, low and last over the given period.
3.23 -10.84% decrease
on 03/22/18
-0.08 (-2.70%) decrease
since 03/20/18
3-Month 2.27 +26.87% increase
on 03/01/18
Period Open:3.05
Price movement based on the high, low and last over the given period.
3.59 -19.78% decrease
on 01/29/18
-0.17 (-5.57%) decrease
since 01/19/18
52-Week 0.70 +311.43% increase
on 08/15/17
Period Open:0.99
Price movement based on the high, low and last over the given period.
3.59 -19.78% decrease
on 01/29/18
+1.89 (+190.91%) increase
since 04/20/17

All market data is provided by Barchart Solutions (will open in new tab). Copyright © 2018.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

More stories below advertisement